These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 8515245)
21. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults. Ashur Y; Adler R; Rowe M; Shouval D Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597 [TBL] [Abstract][Full Text] [Related]
22. Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies. Lagos R; Munoz A; Dumas R; Pichon S; Zambrano B; Levine M; Vidor E Vaccine; 2003 Sep; 21(25-26):3730-3. PubMed ID: 12922104 [TBL] [Abstract][Full Text] [Related]
23. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years. Van Herck K; Van Damme P; Collard F; Thoelen S Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072 [TBL] [Abstract][Full Text] [Related]
24. Simultaneous passive and active immunization against hepatitis A. Leentvaar-Kuijpers A; Coutinho RA; Brulein V; Safary A Vaccine; 1992; 10 Suppl 1():S138-41. PubMed ID: 1335646 [TBL] [Abstract][Full Text] [Related]
25. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile. Riedemann S; Reinhardt G; Frösner GG; Ibarra H; Moraleda L; Hering V; Siegel F; Toledo C; Leon J; Gonzalez JL Vaccine; 1992; 10 Suppl 1():S152-5. PubMed ID: 1335650 [TBL] [Abstract][Full Text] [Related]
26. Vaccination against hepatitis A: comparison of different short-term immunization schedules. Jilg W; Bittner R; Bock HL; Clemens R; Schätzl H; Schmidt M; André FE; Deinhardt F Vaccine; 1992; 10 Suppl 1():S126-8. PubMed ID: 1335642 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine. Beck BR; Hatz CF; Loutan L; Steffen R J Travel Med; 2004; 11(4):201-6. PubMed ID: 15541221 [TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Piazza M; Safary A; Vegnente A; Soncini R; Pensati P; Sardo M; Orlando R; Tosone G; Picciotto L Vaccine; 1999 Feb; 17(6):585-8. PubMed ID: 10075165 [TBL] [Abstract][Full Text] [Related]
29. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864 [TBL] [Abstract][Full Text] [Related]
30. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine. Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638 [TBL] [Abstract][Full Text] [Related]
31. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years. Fan PC; Chang MH; Lee PI; Safary A; Lee CY Vaccine; 1998; 16(2-3):232-5. PubMed ID: 9607035 [TBL] [Abstract][Full Text] [Related]
32. Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule). Wiedermann G; Kundi M; Ambrosch F Acta Trop; 1998 May; 69(2):121-5. PubMed ID: 9588232 [TBL] [Abstract][Full Text] [Related]
33. Persistence of vaccine-induced antibody to hepatitis A virus. Wiedermann G; Ambrosch F; André FE; D'Hondt E; Delem A; Safary A Vaccine; 1992; 10 Suppl 1():S129-31. PubMed ID: 1335643 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis A vaccine. A new convenient single-dose schedule with booster when long-term immunization is warranted. Victor J; Knudsen JD; Nielsen LP; Fomsgaard A; Thybo S; Bygbjerg I; Westh H Vaccine; 1994 Nov; 12(14):1327-9. PubMed ID: 7856299 [TBL] [Abstract][Full Text] [Related]
35. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine. Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the timing of the booster injection after a primary vaccination against hepatitis A. Fujiyama S; Odoh K; Tanaka M; Kuramoto I; Tomita K J Gastroenterol Hepatol; 1997 Feb; 12(2):172-5. PubMed ID: 9083920 [TBL] [Abstract][Full Text] [Related]
37. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine. Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose. Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277 [TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults. Vimolket T; Theamboonlers A; Dumas R; Milcamps B; Forrat R; Poovorawan Y Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]